Cayman Chemical 6 6-Trehalose DIoleate 5mg
A glycolipid; has been used in the generation of LNPs for the delivery of mRNA in vitro and in vivo; LNPs containing 6,6′-TDO and encapsulating mRNA encoding influenza HA increase Ifn-γ, Il-2, and Tnf-α secretion by isolated mouse splenocytes; LNPs containing 6,6′-TDO accumulate in the liver and spleen after intramuscular administration in mice; unlike LNP formulations that do not contain 6,6′-TDO, LNPs containing 6,6′-TDO do not decrease serum levels of BUN or increase serum levels of LDH, troponin I, ALT, and AST in mice; LNPs containing 6,6′-TDO and encapsulating mRNA encoding influenza A HA increase serum IgG1 and IgG2a titers in mice